CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024
Cash flows from operating activities:
Net (loss) income			$ (979)	$ 2,191
Adjustments to reconcile net (loss) income to net cash provided by operating activities
Depreciation and amortization	$ 1,307	$ 1,391	3,900	3,847
Deferred income tax (benefit) expense	(195)	175	(235)	250
Amortization of deferred costs			24	27
Compensation expense related to restricted stock awards			1,648	1,447
Provision for credit losses			372	832
Loss on sale of assets, net			298	1,026
(Gain) on insurance claims			(105)	(78)
Other (gain), net				(1,133)
Barter (revenue) expense, net			(147)	(20)
Deferred and other compensation			(106)	(165)
Changes in assets and liabilities, net of acquisition of AR:
Decrease in current assets			68	1,016
Increase in accounts payable, accrued expenses, and other liabilities			744	901
Total adjustments			6,461	7,950
Net cash provided by operating activities			5,482	10,141
Cash flows from investing activities:
Purchase of short-term investments			(13,619)	(12,993)
Redemption of short-term investments			13,619	15,104
Acquisition of property and equipment (Capital Expenditures)			(2,600)	(3,199)
Acquisition of broadcast properties				(5,711)
Proceeds from sale and disposal of assets			37	176
Proceeds from insurance claims, redemption of investments and other			105	1,221
Other investing activities				(2)
Net cash used in investing activities			(2,458)	(5,404)
Cash flows from financing activities:
Proceeds from long-term debt				5,000
Cash dividends paid			(4,824)	(19,391)
Purchase of treasury shares				(11)
Net cash used in financing activities			(4,824)	(14,402)
Net decrease in cash and cash equivalents			(1,800)	(9,665)
Cash and cash equivalents, beginning of period			18,860	29,582	$ 29,582
Cash and cash equivalents, end of period	$ 17,060	$ 19,917	$ 17,060	$ 19,917	$ 18,860